Novo Nordisk (NVO) stock is dipping after the company's outlook disappointed investors. Yahoo Finance Executive Editor Brian Sozzi shares his thoughts on the stock, the company's trajectory, and where Eli Lilly (LLY) fits into the equation. Video Transcript 00:00 Speaker A Now, another one I'm watching too and this comes top of mind because a couple weeks ago I had Michael Dutar uh on speaking of new CEOs on my on my podcast, Power players. and you should go check it out. It was a really good chat. I think Mike just he flung it. he flung it. He just let it fly. He just said about, you know, where we have lost market share, we need to do marketing a lot better. We need to do a better job.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.